The first 2018 edition of the journal “Time to Unite A Greater Medicon Valley” has just been published early February. Apart from the editorial by MVA CEO, Petter Hartman, you can also read about Nordic Mentor Network for Entrepreneurship (NOME), the future
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
Hosted by MVA member, Healthcare DENMARK, a Swedish delegation consisting of representatives from The Ministry of Health and Social Affairs and The Swedish Association of Local Authorities and Regions visited Denmark on the 29th of January to see and experience innovative
Nobel Prize-winning microscope for protein research in Copenhagen will contribute to strengthening Nordic research into new medicine. Leading protein researchers from four universities in Denmark and Sweden have now established the CryoNet collaboration, which will use the so-called cryo-electron microscope
Bioinformatics firm Mind the Byte, a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services
Did you know that universities, hospitals and companies in our region are currently looking for everything from student assistants to cardiology professors? There might also be a job opening relevant to YOU! See open life science jobs in a region
Our chairman of the MVA Board of Directors, Søren Bregenholt, urges the national decision-makers in Stockholm and Copenhagen to put their differences and last year´s negative “EMA-history” aside and instead focus on the mutual interest in strengthening regional life science
“Since its foundation in 1999, the Copenhagen-based company has been developing antibody-based therapies to treat cancer. Now, it is Europe’s perhaps most fiercely independent biotech, though word on the street is that J&J is considering a buyout after the success of
After closing its first fund, Hadean Ventures, the new €100M VC fund based in Oslo, is ready to inject €100M into Nordic Biotech, according to a story published in Europe´s leading online biotech media, German-based Labiotech.eu “The Nordic region has
The Nordic Life Science insight 2017 introducing you to the technological innovations and innovators that have helped shape the Nordic region, obviously including Medicon Valley, as a global leader in life science has just been published. Among several interesting articles,